HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $594,022 | -3.8% | 18,127 | +3.3% | 0.00% | 0.0% |
| Q2 2023 | $617,409 | +30.1% | 17,545 | +20.7% | 0.00% | +33.3% |
| Q1 2023 | $474,470 | -40.6% | 14,532 | +0.3% | 0.00% | -50.0% |
| Q4 2022 | $798,619 | +23.4% | 14,494 | -0.8% | 0.01% | +20.0% |
| Q3 2022 | $647,000 | -5.0% | 14,609 | +4.6% | 0.01% | 0.0% |
| Q2 2022 | $681,000 | +6.4% | 13,971 | +6.3% | 0.01% | +25.0% |
| Q1 2022 | $640,000 | +7.6% | 13,149 | -5.8% | 0.00% | +33.3% |
| Q4 2021 | $595,000 | +26.9% | 13,955 | +14.1% | 0.00% | 0.0% |
| Q3 2021 | $469,000 | +32.5% | 12,234 | -2.3% | 0.00% | +200.0% |
| Q2 2021 | $354,000 | +195.0% | 12,525 | +246.0% | 0.00% | – |
| Q1 2021 | $120,000 | -8.4% | 3,620 | +0.3% | 0.00% | – |
| Q4 2020 | $131,000 | – | 3,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |